CORE--DEVELOPMENTAL SUPPORT

AECOM CFAR打算继续利用发展资金 招募两名艾滋病研究新手，他们以前没有过 在这一领域获得了相当于个人RO1的支持。在第六年， 具有以下条件的分子或细胞免疫学家将优先考虑 疫苗研发方面的专业知识。将提供最高限额的资金 已经两年了。招聘机制将仿效 CFAR和AECOM癌症已经做出了类似的努力 研究中心和肝脏研究中心。该职位也将是 在科学期刊上刊登广告，并为招聘提供便利 少数族裔候选人，信将写给研究生院，并写上 主要关注少数族裔节目。申请将由Dr。 并提交指导委员会和机构间咨询委员会批准。 来自机构内部和外部的潜在新调查人员 将根据方向盘的建议进行评估和选择 委员会、内部(IAC)和外部咨询(IAC)委员会。 我们将继续每年为AECOM的一项可行性研究提供支持 调查员，准备开发优先申请 已查看支持。 最后，将为两个不断发展的研究机会预留资金 在AECOM调查人员中。这项支持将限制在六个月内 解决正在出现的需要快速解决的关键想法。 将鼓励涉及基础和临床应用的应用 研究合作。

The AECOM CFAR intends to continue to utilize developmental funds to recruit two investigators new to AIDS research, who have not previously received individual RO1 equivalent support in this field. In year 6 the first priority will be given to a molecular or cellular immunologist with expertise in vaccine development. Funding will be provided for a maximum of two years. Mechanisms of recruitment will be modelled after comparable efforts already in place in the CFAR, and the AECOM Cancer Research Center and Liver Research Center. The position will also be advertised in scientific journals and, to facilitate recruitment of minority candidates, letters will be written to graduate schools with a major focus on minority programs. Applications will be reviewed by Dr. Lilly and submitted for approval of the Steering Committee and the IAC. Potential new investigators from within the institution and from outside will be evaluated and selected based on recommendations of the Steering Committee, Internal (IAC) and External Advisory (IAC) Committee. We will continue yearly support for one feasibility study by an AECOM investigator, preparatory to the development of an application for prior reviewed support. Finally, funds will be set aside for two evolving research opportunities among AECOM investigators. This support will be limited to six months to address arising critical ideas that demand rapid solution. Encouragement will be given to applications entailing basic and clinical research collaboration.